Research Topic · Peer-Reviewed

Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is a group of epithelial lung malignancies that together account for the large majority of lung cancer diagnoses and are distinguished from small cell lung cancer by their cell appearance under the microscope and their generally slower growth and different treatment response. NSCLC…

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 63× across the literature 🔖 ISSN 2639-1716 🗓 Reviewed July 2026

Overview

Non-small cell lung cancer (NSCLC) is a group of epithelial lung malignancies that together account for the large majority of lung cancer diagnoses and are distinguished from small cell lung cancer by their cell appearance under the microscope and their generally slower growth and different treatment response. NSCLC encompasses several histological subtypes, principally adenocarcinoma, squamous cell carcinoma, and large cell carcinoma, which arise from the cells lining the airways and alveoli. The disease often presents at an advanced stage, producing symptoms such as persistent cough, breathlessness, chest pain, and weight loss, and it can spread to distant sites including the adrenal glands, brain, and bone. Management is guided by stage and may combine surgical resection, radiotherapy, cytotoxic chemotherapy, targeted agents directed at specific molecular drivers, and immunotherapy that releases the brakes on antitumour immune responses. Within this field, the journal publishes peer-reviewed work touching on aspects such as the role of heparin in lung cancer, patterns of isolated adrenal metastasis, the influence of immunotherapy on surgical practice and pulmonary resection rates, and broader cancer-biology and biomarker questions including in vitro tumour-cell modelling and immune checkpoint pathways. Research also addresses supportive concerns such as cancer cachexia and nutritional management, reflecting the clinical breadth of NSCLC care.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2017

The Role of Heparin in Lung Cancer

Abu Arab WalidCorresponding author
Service de Chirurgie thoracique, Université de Sherbrooke, Québec, Canada
Exact topic Neoplasms Cited by 7 doi:10.14302/issn.2639-1716.jn-17-1499
2019

Avant Garde Alleviation -Cancer Immunotherapy

Bajaj AnubhaCorresponding author
MD. (Pathology) Panjab University, Department of Histopathology, A.B. Diagnostics, A-1, Ring Road , Rajouri Garden, New Delhi, 110027, India.
Exact topic Clinical and Diagnostic Pathology doi:10.14302/issn.2689-5773.jcdp-19-3061

How this research is being cited

The 12 articles above have been cited 63 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Non-Small Cell Lung Cancer, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Neoplasms (ISSN 2639-1716).

Journal editorial board
Chi Leung CHIANG · Hong Kong Diogo Moura · Portugal Argyrios Tzamalis · Greece

This page summarises published research for orientation; it is not medical or professional advice.